Identification of a Novel Methylated Gene in Nasopharyngeal Carcinoma: TTC40

Abstract

To further explore the epigenetic changes in nasopharyngeal carcinoma (NPC), methylation-sensitive arbitrarily primed PCR was performed on NPC biopsies and nontumor nasopharyngeal samples. We have shown mainly two DNA fragments that appeared to be differentially methylated in NPCs versus nontumors. The first, defined as hypermethylated, corresponds to a CpG island at the 5′-end of the tetratricopeptide repeat domain 40 (TTC40) gene, whereas the second, defined as hypo-methylated, is located on repetitive sequences at chromosomes 16p11.1 and 13.1. Thereafter, the epigenetic alteration on the 5′-TTC40 gene was confirmed by methylation-specific PCR, showing a significant aberrant methylation in NPCs, compared to nontumors. In addition, the bisulfite sequencing analysis has shown a very high density of methylated cytosines in C15, C17, and X666 NPC xenografts. To assess whether TTC40 gene is silenced by aberrant methylation, we examined the gene expression by reverse transcription-PCR. Our analysis showed that the mRNA expression was significantly lower in tumors than in nontumors, which is associated with 5′-TTC40 gene hypermethylation. In conclusion, we found that the 5′-TTC40 gene is frequently methylated and is associated with the loss of mRNA expression in NPCs. Hypermethylation of 5′-TTC40 gene might play a role in NPC development; nevertheless, other studies are needed.

Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects

“…TTC40 encodes cilia and flagella associated protein 46, which is reported to play a role in the occurrence of nasopharyngeal carcinoma and acute myeloid leukemia [ 39 , 40 ]. In our study, zebrafish with knockdown of this gene did not exhibit an abnormal phenotype in terms of LR patterning.…”

Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction

“…In all samples, adequate amounts of RNA were extracted using commercially available kits, with ≤1 ng of sample RNA/reaction required to obtain robust ddPCR results. In contrast, from 20 to 50 ng per reaction of RNA is typically required to perform RT‐qPCR from head and neck cancer cells …”